196 related articles for article (PubMed ID: 34858879)
1. Effective Genome Editing in
Espada CR; Quilles JC; Albuquerque-Wendt A; Cruz MC; Beneke T; Lorenzon LB; Gluenz E; Cruz AK; Uliana SRB
Front Cell Infect Microbiol; 2021; 11():772311. PubMed ID: 34858879
[TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR/Cas9-Based Reverse Genetics in
Adaui V; Kröber-Boncardo C; Brinker C; Zirpel H; Sellau J; Arévalo J; Dujardin JC; Clos J
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33007987
[TBL] [Abstract][Full Text] [Related]
3. Targeted Deletion of Centrin in
Sharma R; Avendaño Rangel F; Reis-Cunha JL; Marques LP; Figueira CP; Borba PB; Viana SM; Beneke T; Bartholomeu DC; de Oliveira CI
Front Cell Infect Microbiol; 2021; 11():790418. PubMed ID: 35252020
[No Abstract] [Full Text] [Related]
4. LeishGEdit: A Method for Rapid Gene Knockout and Tagging Using CRISPR-Cas9.
Beneke T; Gluenz E
Methods Mol Biol; 2019; 1971():189-210. PubMed ID: 30980304
[TBL] [Abstract][Full Text] [Related]
5. Testing the CRISPR-Cas9 and glmS ribozyme systems in Leishmania tarentolae.
Turra GL; Schneider L; Liedgens L; Deponte M
Mol Biochem Parasitol; 2021 Jan; 241():111336. PubMed ID: 33166572
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
Zhang WW; Matlashewski G
mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
[TBL] [Abstract][Full Text] [Related]
7. Ros3 (Lem3p/CDC50) Gene Dosage Is Implicated in Miltefosine Susceptibility in
Espada CR; Albuquerque-Wendt A; Hornillos V; Gluenz E; Coelho AC; Uliana SRB
ACS Infect Dis; 2021 Apr; 7(4):849-858. PubMed ID: 33724800
[TBL] [Abstract][Full Text] [Related]
8. A transient CRISPR/Cas9 expression system for genome editing in Trypanosoma brucei.
Shaw S; Knüsel S; Hoenner S; Roditi I
BMC Res Notes; 2020 Jun; 13(1):268. PubMed ID: 32493474
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic analysis of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis.
Valdivia HO; Reis-Cunha JL; Rodrigues-Luiz GF; Baptista RP; Baldeviano GC; Gerbasi RV; Dobson DE; Pratlong F; Bastien P; Lescano AG; Beverley SM; Bartholomeu DC
BMC Genomics; 2015 Sep; 16(1):715. PubMed ID: 26384787
[TBL] [Abstract][Full Text] [Related]
10. Complexity of the major surface protease (msp) gene organization in Leishmania (Viannia) braziliensis: evolutionary and functional implications.
Victoir K; Arevalo J; De Doncker S; Barker DC; Laurent T; Godfroid E; Bollen A; Le Ray D; Dujardin JC
Parasitology; 2005 Aug; 131(Pt 2):207-14. PubMed ID: 16145937
[TBL] [Abstract][Full Text] [Related]
11. Presence of parasite DNA in clinically unaffected nasal mucosa during cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Canário A; Queiroz M; Cunha G; Cavalcante T; Riesz V; Sharma R; de Noronha A; Correia T; Barral-Netto M; Barral A; Khouri R; Boaventura V
Clin Microbiol Infect; 2019 Apr; 25(4):515.e5-515.e7. PubMed ID: 30616010
[TBL] [Abstract][Full Text] [Related]
12. Organization of H locus conserved repeats in Leishmania (Viannia) braziliensis correlates with lack of gene amplification and drug resistance.
Dias FC; Ruiz JC; Lopes WC; Squina FM; Renzi A; Cruz AK; Tosi LR
Parasitol Res; 2007 Aug; 101(3):667-76. PubMed ID: 17393181
[TBL] [Abstract][Full Text] [Related]
13. Big is not better: Comparing two alpha-Gal-bearing glycotopes in neoglycoproteins as biomarkers for Leishmania (Viannia) braziliensis infection.
Montoya AL; Gil ER; Vinales I; Estevao IL; Taboada P; Torrico MC; Torrico F; Marco JD; Almeida IC; Michael K
Carbohydr Res; 2024 Feb; 536():109015. PubMed ID: 38198982
[TBL] [Abstract][Full Text] [Related]
14. Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.
Guerra JA; Prestes SR; Silveira H; Coelho LI; Gama P; Moura A; Amato V; Barbosa Md; Ferreira LC
PLoS Negl Trop Dis; 2011 Mar; 5(3):e980. PubMed ID: 21408116
[TBL] [Abstract][Full Text] [Related]
15. Polymerase chain reaction-based method for the identification of Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in mucosal tissues conserved in paraffin.
Prestes SR; Guerra JA; Romero GA; Magalhaes LK; Santana RA; Maciel MG; Custódio A; Barbosa Md; Silveira H
Rev Soc Bras Med Trop; 2015; 48(5):555-9. PubMed ID: 26516964
[TBL] [Abstract][Full Text] [Related]
16. Novel CRISPR-based detection of
Dueñas E; Nakamoto JA; Cabrera-Sosa L; Huaihua P; Cruz M; Arévalo J; Milón P; Adaui V
Front Microbiol; 2022; 13():958693. PubMed ID: 36187950
[TBL] [Abstract][Full Text] [Related]
17. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
18. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of Casein Kinase 1.1 in
Martel D; Beneke T; Gluenz E; Späth GF; Rachidi N
Biomed Res Int; 2017; 2017():4635605. PubMed ID: 29333442
[TBL] [Abstract][Full Text] [Related]
20. Application of CRISPR/Cas9-Mediated Genome Editing in Leishmania.
Zhang WW; Lypaczewski P; Matlashewski G
Methods Mol Biol; 2020; 2116():199-224. PubMed ID: 32221923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
